Essenlix Corp, based in Monmouth Junction, NJ, is a digital health and wellness company that has developed a groundbreaking instant mobile health self-test platform called iMOST. This innovative platform allows both professionals and laypeople to accurately perform diagnostic health tests anywhere, anytime, using a single drop of body fluid and a handheld portable device, such as a smartphone, delivering clinical lab-quality results within minutes at a low cost.
With a focus on removing barriers in digital health, Essenlix aims to make iMOST available to a global population of 7 billion people. The company's first product, iMOST-CBC, offers complete blood count testing for research purposes and pending FDA approval, diagnostics, with plans to expand its product pipeline to include various other assays. By revolutionizing diagnostic testing through nanotechnology, advanced imaging, and artificial intelligence, Essenlix is transforming the way individuals monitor and manage their health.
Generated from the website